Recent
- Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier
- Psychedelic Business Spotlight – June 17
- Psychedelic Business Spotlight – April 22
- Psychedelic Business Spotlight – February 4
- Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for Psychedelics
- Psychedelic Business Spotlight — January 28
- Interview with James Lanthier, CEO of Mindset Pharma
- Psychedelic Business Spotlight — January 7
- Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds
- Psychedelic Business Spotlight – December 31
Mindset Pharma
Public Company
[stockdio-historical-chart symbol="MSSTF" stockExchange="" palette="financial-light"]
